Search - tctmd.com

Displaying 201 - 220 of 659

Sort: Relevancy | Date

Presentation TCT 2017

TCT 14: Safety and Clinical Performance of the Drug-Eluting Absorbable Metal Scaffold in the Treatment of Subjects With De Novo Lesions in Native Coronary Arteries at 12-Month Follow-up - BIOSOLVE-II and BIOSOLVE-III

Presenter: Stephan Achenbach, Jacques J. Koolen, Ron Waksman

October 31, 2017

Presentation TCT 2017

The High-Bleeding-Risk Patient: Physician-Scientist Perspectives on Appropriate Patients and DAPT Duration

Presenter: Mitchell W. Krucoff, P.F. Adrian Magee, Marie-Claude Morice

October 31, 2017

Presentation TCT 2017

Reasonable and Unreasonable Bifurcations for Bioresorbable Scaffolds, and Technique (With Case Examples)

Presenter: Antonio Colombo, Manuel Pan, Jens Flensted Lassen

October 30, 2017

Presentation TCT 2017

Bioresorbable Scaffolds in Complex SFA Lesions: Case Examples and Data

Presenter: Subhash Banerjee, Tony Das

October 30, 2017

Presentation TCT 2017

Is There a Role for Dedicated Stents or Bioresorbable Scaffolds in the Treatment of Complex Bifurcation Disease?

Presenter: Walter Desmet, Guy J. Friedrich, Eduard Margetic, Christophe Dubois

October 30, 2017

Presentation TCT 2017

Case #8: Bioresorbable Scaffold Implantation in Left Main Coronary Artery - Feasibility and Wisdom (With Discussion)

Presenter: Stephan Achenbach, Salvatore Brugaletta, Rajiv Ananthakrishna

October 30, 2017

Presentation TCT 2017

Case #7: Malapposition in a Bioresorbable Scaffold - Identification and the Decision Whether to Treat (With Discussion)

Presenter: Stephan Achenbach, Salvatore Brugaletta

October 30, 2017

Presentation TCT 2017

Case #6: How to Implant Bioresorbable Scaffolds in Diffuse Disease (With Discussion)

Presenter: Stephan Achenbach, Salvatore Brugaletta

October 30, 2017

Presentation TCT 2017

Case #5: How to Implant Bioresorbable Scaffolds in Calcified Lesions (With Discussion)

Presenter: Stephan Achenbach, Salvatore Brugaletta, Antonio Colombo

October 30, 2017

Presentation TCT 2017

Case #4: How to Use Imaging During Bioresorbable Scaffold Implantation (With Discussion)

Presenter: Stephan Achenbach, Salvatore Brugaletta, Daniel Chamie

October 30, 2017

Presentation TCT 2017

Case #3: How to Implant Bioresorbable Scaffolds in CTO (With Discussion)

Presenter: Stephan Achenbach, Salvatore Brugaletta, Alessio G La Manna

October 30, 2017

Presentation TCT 2017

Case #2: How to Implant Bioresorbable Scaffolds in Bifurcation Lesions (With Discussion)

Presenter: Stephan Achenbach, Salvatore Brugaletta, Javier Suárez de Lezo

October 30, 2017

Presentation TCT 2017

Case #1: How to Implant Bioresorbable Scaffolds in STEMI (With Discussion)

Presenter: Stephan Achenbach, Salvatore Brugaletta, Petr Tousek

October 30, 2017

Presentation TCT 2017

Bioresorbable Scaffolds in a Coronary CTO

Presenter: Teguh Santoso, Yoshito Yamamoto

October 30, 2017

Presentation TCT 2017

Predicting The Future: Will the ABSORB III/IV Ten-Year Results Change How We Currently View Bioresorbable Vascular Scaffolds?

Presenter: C. Michael Gibson, Stephan Windecker, Stephan Achenbach

October 30, 2017

Presentation TCT 2017

Next Generation BRS Platforms

Presenter: Gary S. Mintz, Seung-Jung Park, Alan C. Yeung

October 29, 2017

Presentation TCT 2017

Bioresorbable Scaffolds and Outcomes 2017

Presenter: Joseph P. Carrozza Jr, Jose M. Wiley, Jochen Wöhrle

October 29, 2017

Presentation TCT 2017

BRS Randomized Trials: What Was Wrong the Lesions, the Scaffold, or the Technique?

Presenter: Gary S. Mintz, Seung-Jung Park

October 29, 2017

Presentation TCT 2017

Lessons from the ABSORB Clinical Program for the Future

Presenter: Gary S. Mintz, Seung-Jung Park, Patrick W. Serruys

October 29, 2017

Presentation TCT 2017

Bioresorbable Scaffolds Are Here to Stay!

Presenter: Antonio Colombo, Stephen G. Ellis, Ron Waksman

October 29, 2017

Advertisement

TCT 14: Safety and Clinical Performance of the Drug-Eluting Absorbable Metal Scaffold in the Treatment of Subjects With De Novo Lesions in Native Coronary Arteries at 12-Month Follow-up - BIOSOLVE-II and BIOSOLVE-III

The High-Bleeding-Risk Patient: Physician-Scientist Perspectives on Appropriate Patients and DAPT Duration

Reasonable and Unreasonable Bifurcations for Bioresorbable Scaffolds, and Technique (With Case Examples)

Bioresorbable Scaffolds in Complex SFA Lesions: Case Examples and Data

Is There a Role for Dedicated Stents or Bioresorbable Scaffolds in the Treatment of Complex Bifurcation Disease?

Case #8: Bioresorbable Scaffold Implantation in Left Main Coronary Artery - Feasibility and Wisdom (With Discussion)

Case #7: Malapposition in a Bioresorbable Scaffold - Identification and the Decision Whether to Treat (With Discussion)

Case #6: How to Implant Bioresorbable Scaffolds in Diffuse Disease (With Discussion)

Case #5: How to Implant Bioresorbable Scaffolds in Calcified Lesions (With Discussion)

Case #4: How to Use Imaging During Bioresorbable Scaffold Implantation (With Discussion)

Case #3: How to Implant Bioresorbable Scaffolds in CTO (With Discussion)

Case #2: How to Implant Bioresorbable Scaffolds in Bifurcation Lesions (With Discussion)

Case #1: How to Implant Bioresorbable Scaffolds in STEMI (With Discussion)

Bioresorbable Scaffolds in a Coronary CTO

Predicting The Future: Will the ABSORB III/IV Ten-Year Results Change How We Currently View Bioresorbable Vascular Scaffolds?

Next Generation BRS Platforms

Bioresorbable Scaffolds and Outcomes 2017

BRS Randomized Trials: What Was Wrong the Lesions, the Scaffold, or the Technique?

Lessons from the ABSORB Clinical Program for the Future

Bioresorbable Scaffolds Are Here to Stay!

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content